Matches in SemOpenAlex for { <https://semopenalex.org/work/W4238504673> ?p ?o ?g. }
- W4238504673 endingPage "1030" @default.
- W4238504673 startingPage "1022" @default.
- W4238504673 abstract "Pancreatic endocrine tumors (PETs) have variable prognoses, and predictors of survival are lacking. PETs can be difficult to distinguish histologically from aggressive pancreatic neoplasms such as acinar cell carcinoma. Telomerase is a ribonuclear protein that maintains the length of the telomere and induces cell immortality. Telomerase is present in 95% of pancreatic adenocarcinoma and is associated with aggressive tumor behavior. Our aim is to determine telomerase activity in PETs and investigate its potential role as a prognostic indicator.Telomerase detection using the telomeric repeat amplification protocol was performed on frozen surgical archived pancreatic endocrine tissue from 30 patients with PETs identified by light microscopy (hematoxylin-eosin stain). All results were confirmed with internal controls. A patient's survival was measured from the time of surgery. Acinar cell differentiation (presence of zymogen granules) was determined by electron microscopy. Follow-up data were acquired via telephone interview, medical record review, and death certificates.Three of 30 PETs diagnosed by light microscopy were telomerase positive: three were considered nonfunctional, and two of these three patients had extrapancreatic disease. All three telomerase-positive cases were reclassified as either acinar cell carcinoma (two cases) or mixed acinar-endocrine cell carcinoma (one case). All three patients (mean age = 63 yr) died from tumor progression within 2 yr of surgery (mean = 1.6 yr +/- 0.5 SD). The remaining PETs were telomerase negative: 13 insulinomas, four nonfunctional, two sporadic glucagonomas, one gastrinoma, one vipoma, one carcinoidlike PET, and five PETs from three patients with multiple endocrine neoplasm syndrome type I and two patients with von Hippel-Lindau syndrome. Excluding insulinomas, 12 of 14 patients with telomerase-negative PETs had extrapancreatic disease. Nevertheless, Kaplan-Meier survival estimates for these 12 patients were significantly longer than for patients with telomerase-positive acinar cell carcinoma (92% vs 0% at 2 yr, p = 0.001, log rank test). The survival of all telomerase-negative PETs (n = 27) was significantly longer than that of the patients with telomerase-positive acinar cell carcinoma (93% vs 0% at 2 yr, p = 0.0001).Telomerase activity helps to identify acinar cell carcinomas that histologically resemble PETs, which accounts for the poor prognosis demonstrated in these patients. The absence of telomerase activity in most PETs may be responsible for their indolent clinical course. Telomerase may identify potentially progressive tumors, such as acinar cell carcinoma, and may be useful in selecting patients for more aggressive treatment." @default.
- W4238504673 created "2022-05-12" @default.
- W4238504673 creator A5007293606 @default.
- W4238504673 creator A5027272179 @default.
- W4238504673 creator A5030055653 @default.
- W4238504673 creator A5036774311 @default.
- W4238504673 creator A5057907657 @default.
- W4238504673 creator A5064124197 @default.
- W4238504673 creator A5079808476 @default.
- W4238504673 creator A5085588081 @default.
- W4238504673 creator A5089255232 @default.
- W4238504673 date "2002-04-01" @default.
- W4238504673 modified "2023-10-17" @default.
- W4238504673 title "Telomerase activity in pancreatic endocrine tumors" @default.
- W4238504673 cites W1587107897 @default.
- W4238504673 cites W1900522478 @default.
- W4238504673 cites W1917620582 @default.
- W4238504673 cites W1974402253 @default.
- W4238504673 cites W1992733063 @default.
- W4238504673 cites W1997155752 @default.
- W4238504673 cites W2000971601 @default.
- W4238504673 cites W2030976397 @default.
- W4238504673 cites W2036212440 @default.
- W4238504673 cites W2042221269 @default.
- W4238504673 cites W2053533762 @default.
- W4238504673 cites W2100550233 @default.
- W4238504673 cites W2108482850 @default.
- W4238504673 cites W2132517435 @default.
- W4238504673 cites W2143063758 @default.
- W4238504673 cites W3134503611 @default.
- W4238504673 cites W4241014232 @default.
- W4238504673 cites W4246476947 @default.
- W4238504673 cites W4252826874 @default.
- W4238504673 doi "https://doi.org/10.1111/j.1572-0241.2002.05623.x" @default.
- W4238504673 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12003383" @default.
- W4238504673 hasPublicationYear "2002" @default.
- W4238504673 type Work @default.
- W4238504673 citedByCount "14" @default.
- W4238504673 countsByYear W42385046732013 @default.
- W4238504673 countsByYear W42385046732015 @default.
- W4238504673 countsByYear W42385046732018 @default.
- W4238504673 countsByYear W42385046732020 @default.
- W4238504673 crossrefType "journal-article" @default.
- W4238504673 hasAuthorship W4238504673A5007293606 @default.
- W4238504673 hasAuthorship W4238504673A5027272179 @default.
- W4238504673 hasAuthorship W4238504673A5030055653 @default.
- W4238504673 hasAuthorship W4238504673A5036774311 @default.
- W4238504673 hasAuthorship W4238504673A5057907657 @default.
- W4238504673 hasAuthorship W4238504673A5064124197 @default.
- W4238504673 hasAuthorship W4238504673A5079808476 @default.
- W4238504673 hasAuthorship W4238504673A5085588081 @default.
- W4238504673 hasAuthorship W4238504673A5089255232 @default.
- W4238504673 hasConcept C104317684 @default.
- W4238504673 hasConcept C125473707 @default.
- W4238504673 hasConcept C126322002 @default.
- W4238504673 hasConcept C142724271 @default.
- W4238504673 hasConcept C177336024 @default.
- W4238504673 hasConcept C204232928 @default.
- W4238504673 hasConcept C2777546739 @default.
- W4238504673 hasConcept C2778764654 @default.
- W4238504673 hasConcept C2991930265 @default.
- W4238504673 hasConcept C46699223 @default.
- W4238504673 hasConcept C54355233 @default.
- W4238504673 hasConcept C552990157 @default.
- W4238504673 hasConcept C55493867 @default.
- W4238504673 hasConcept C71315377 @default.
- W4238504673 hasConcept C71924100 @default.
- W4238504673 hasConcept C86803240 @default.
- W4238504673 hasConcept C90924648 @default.
- W4238504673 hasConcept C94581717 @default.
- W4238504673 hasConceptScore W4238504673C104317684 @default.
- W4238504673 hasConceptScore W4238504673C125473707 @default.
- W4238504673 hasConceptScore W4238504673C126322002 @default.
- W4238504673 hasConceptScore W4238504673C142724271 @default.
- W4238504673 hasConceptScore W4238504673C177336024 @default.
- W4238504673 hasConceptScore W4238504673C204232928 @default.
- W4238504673 hasConceptScore W4238504673C2777546739 @default.
- W4238504673 hasConceptScore W4238504673C2778764654 @default.
- W4238504673 hasConceptScore W4238504673C2991930265 @default.
- W4238504673 hasConceptScore W4238504673C46699223 @default.
- W4238504673 hasConceptScore W4238504673C54355233 @default.
- W4238504673 hasConceptScore W4238504673C552990157 @default.
- W4238504673 hasConceptScore W4238504673C55493867 @default.
- W4238504673 hasConceptScore W4238504673C71315377 @default.
- W4238504673 hasConceptScore W4238504673C71924100 @default.
- W4238504673 hasConceptScore W4238504673C86803240 @default.
- W4238504673 hasConceptScore W4238504673C90924648 @default.
- W4238504673 hasConceptScore W4238504673C94581717 @default.
- W4238504673 hasIssue "4" @default.
- W4238504673 hasLocation W42385046731 @default.
- W4238504673 hasLocation W42385046732 @default.
- W4238504673 hasOpenAccess W4238504673 @default.
- W4238504673 hasPrimaryLocation W42385046731 @default.
- W4238504673 hasRelatedWork W133656616 @default.
- W4238504673 hasRelatedWork W2010947609 @default.
- W4238504673 hasRelatedWork W2036195511 @default.
- W4238504673 hasRelatedWork W2062729526 @default.
- W4238504673 hasRelatedWork W2077080077 @default.